Filing Analysis

βœ‚οΈ Reverse Stock Split Filed Oct 16, 2025
🟠 HIGH

BioScience Health Innovations, Inc. (BHIC) has implemented a 1-for-4 reverse stock split effective September 10, 2025. The action was approved via written consent of a majority of voting shares.

🚩 Red Flags

  • Reverse stock split (often used to boost share price to meet exchange listing requirements or avoid delisting).
  • Potential signal of significant loss in market capitalization or downward pressure on share price leading up to the split.

πŸ“‹ Key Facts

  • Reverse split ratio is 4:1 (4 shares become 1 share).
  • The reverse split became effective on September 10, 2025.
  • The action was approved by written consent of a majority of the Company's voting shares.
  • Amendment to the Restated Certificate of Incorporation was filed with the Secretary of State of Nevada.
πŸ“„ Other SEC Filing Filed Mar 17, 2025
βšͺ LOW

The Company has officially changed its corporate name from 'Nowtransit, Inc.' to 'BioScience Health Innovations, Inc.', effective February 21, 2025. This change was approved by the Board of Directors and involves amendments to the Certificate of Incorporation and Bylaws.

🚩 Red Flags

  • Name changes in micro-cap companies can sometimes be used to signal a pivot into trending sectors (e.g., 'BioScience') without fundamental business shifts, though this is not explicitly indicated here.

πŸ“‹ Key Facts

  • Effective date of name change: February 21, 2025.
  • Former name: Nowtransit, Inc.
  • New name: BioScience Health Innovations, Inc.
  • The amendment to the Certificate of Incorporation was filed with the Secretary of State of Nevada.
  • The Board approved an amendment and restatement of the Bylaws to reflect the new name.
πŸ›’ Asset Acquisition Filed Jun 25, 2024
🟠 HIGH

Nowtransit Inc filed an amended 8-K to provide Form 10 disclosures following a reverse merger with Best Labs, Inc. completed on March 10, 2023. The transaction resulted in the company transitioning from a shell company to an operating business focused on selling dietary supplements.

🚩 Red Flags

  • The company was a 'shell company' immediately prior to the merger.
  • Significant dilution: The issuance of 34.3M shares represents a massive change in equity structure.
  • Related-party transaction: Ageless Holdings LLC, which serves as the company's supply chain manager, is managed by the Company's CEO, Darren Lopez.

πŸ“‹ Key Facts

  • Transaction consummated on March 10, 2023, via a Share Exchange Agreement with Best Labs, Inc.
  • Best Labs, Inc. became a wholly-owned subsidiary of Nowtransit Inc.
  • Nowtransit issued 34,371,100 shares of common stock to Best shareholders, representing ~85.39% of the company's total outstanding shares post-closing.
  • The transaction was accounted for as a reverse merger; Best Labs is the accounting acquirer and Nowtransit is the accounting acquiree.
  • Company business focus shifted from online delivery to marketing dietary supplements (e.g., Be On-Guard, NeuroPro Plus) through online and other channels.
πŸ” Auditor Change Filed May 22, 2024
🟑 MEDIUM

Nowtransit Inc. filed an 8-K reporting the dismissal of its previous independent auditor, Spiegel Accountancy Corp., and confirming the appointment of Mac Accounting Group & CPAs LLP following a prior reorganization/merger.

🚩 Red Flags

  • Historical 'substantial doubt about the Company’s ability to continue as a going concern' was noted in the fiscal year ended August 31, 2022 report.
  • The filing involves a complex history of reorganization and recapitalization (merger with Best 365 Labs, LLC).

πŸ“‹ Key Facts

  • Spiegel Accountancy Corp. was dismissed as the independent registered public accounting firm.
  • Mac Accounting Group & CPAs LLP is the current appointed independent auditor, having served Best 365 Labs, LLC prior to the merger.
  • The company underwent a recapitalization/merger with Best 365 Labs, LLC that consummated on March 10, 2023.
  • Spiegel's reports for fiscal years ended August 31, 2022 and 2021 did not contain adverse opinions or disclaimers of opinion (except for a prior going concern explanatory paragraph in 2022).
  • The company stated there were no disagreements with Spiegel regarding accounting principles, practices, or auditing procedures.
Disclaimer: This analysis is generated by AI and is for informational purposes only. It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities. Always review the original SEC filings and consult a financial advisor before making investment decisions.

Get real-time alerts for BHIC

Subscribers receive AI-powered analysis within minutes of new SEC filings — not days later.

Start 14-Day Free Trial